Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  St. Jude Medical, Inc.    STJ

Delayed Quote. Delayed  - 09/28 08:34:12 pm
79.7301 USD   +0.16%
07:45p ST JUDE MEDICAL : 2016 Shareholders Meeting
09/21 Intermountain Healthcare Announces 2016 Supplier Award Winners
09/21 CONSTANT MOVEME : Valeant Pharmaceuticals International, Inc. St. J..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/22/2016 09/23/2016 09/26/2016 09/27/2016 09/28/2016 Date
79.61(c) 79.64(c) 79.06(c) 79.91(c) 79.7301 Last
2 229 774 1 174 683 1 866 214 2 345 013 779 974 Volume
+0.21% +0.04% -0.73% +1.08% +0.16% Change
More quotes
Financials ($)
Sales 2016 6 052 M
EBIT 2016 1 513 M
Net income 2016 934 M
Debt 2016 4 898 M
Yield 2016 1,46%
Sales 2017 6 357 M
EBIT 2017 1 607 M
Net income 2017 1 147 M
Debt 2017 3 841 M
Yield 2017 1,57%
P/E ratio 2016 24,94
P/E ratio 2017 20,48
EV / Sales2016 4,57x
EV / Sales2017 4,19x
Capitalization 22 769 M
More Financials
Company
St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain.The company was founded by Manuel A.... 
More about the company
Surperformance© ratings of St. Jude Medical, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ST. JUDE MEDICAL, INC.
07:45p ST JUDE MEDICAL : 2016 Shareholders Meeting
09/23 ST JUDE MEDICAL : Special Notice - Curved Cannulas for Neurotherm RFA machine
09/21 Intermountain Healthcare Announces 2016 Supplier Award Winners
09/21 CONSTANT MOVEMENTS OF STOCKS : Valeant Pharmaceuticals International, Inc. St. ..
09/21 SPECIAL NOTICE - INTENT TO SOLE SOUR : St. Jude Medical, Inc.
09/21 ST JUDE MEDICAL : Assigned Patent
09/17DJJ&J to Buy Abbott Eye Business -- WSJ
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 2nd Update
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 3rd Update
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- Update
More news
Sector news : Medical Devices & Implants
08/26DJMEDTRONIC : Files 8K - Increased Financial Obligation
08/25DJMEDTRONIC : Profit Rises, Helped by Lower Expenses
08/10 FTSE notches up fifth day of gains on firm financials
08/04 Business groups sue over new U.S. limit on tax-driven foreign buyouts
08/04DJBECTON DICKINSON : Tops Earnings Views, Cuts Revenue Guidance
More sector news : Medical Devices & Implants
News from SeekingAlpha
09/21 Presenting Apple's First Car
09/18 Abbott Laboratories - Reducing Leverage And Increasing Focus Following Vision..
09/14 Will The Market Catch Hillary's Bug?
09/08 Google Enters New Era
09/07 Bank Of America M&A Imminent
Advertisement
Chart ST. JUDE MEDICAL, INC.
Duration : Period :
St. Jude Medical, Inc. Technical Analysis Chart | STJ | US7908491035 | 4-Traders
Full-screen chart
Technical analysis trends ST. JUDE MEDICAL,...
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 79,7 $
Spread / Average Target -0,26%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael T. Rousseau President, Chief Executive Officer & Director
Daniel J. Starks Executive Chairman
Scott P. Thome Vice President-Global Operations & Supply Chain
Donald J. Zurbay Chief Financial Officer & Vice President
Mark D. Carlson Chief Medical Officer & VP-Global Clinical Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ST. JUDE MEDICAL, INC.29.37%22 527
STRYKER CORPORATION26.75%43 498
SMITH & NEPHEW PLC2.65%14 247
WRIGHT MEDICAL GROUP N..1.70%2 437
GLAUKOS CORP59.01%1 263
ENDOLOGIX, INC.30.51%1 049
More Results